SA58 Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2452
https://www.valueinhealthjournal.com/article/S1098-3015(22)04657-5/fulltext
Title :
SA58 Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04657-5&doi=10.1016/j.jval.2022.09.2452
First page :
Section Title :
Open access? :
No
Section Order :
12018